Citius Pharmaceuticals Reports Topline Data from the Pivotal Phase 3 Study of Cancer Immunotherapy.
Citius Pharmaceuticals Reports Topline Data from the Pivotal Phase 3 Study of Cancer Immunotherapy I/ONTAK (E7777) for the Treatment of Persistent or Recurrent Cutaneous...
Surna Cultivation Technologies Signs Contract for New Addition to Product Portfolio
Converted Air Sanitization Product Partnership to Customer Contract in Under Thirty Days
Louisville, Colorado, April 05, 2022 (GLOBE NEWSWIRE) -- CEA Industries Inc. (NASDAQ: CEAD, CEADW) subsidiary, Surna...
Report: First Vaccines, then Antivirals. Will the Anti-Inflammatory Be the Next Success Story in...
New Report on Revive Therapeutics (RVVTF, RVV). Ushering in Advances in Anti-Inflammatory and Antioxidant Drugs, as a Tool Against Covid.
Early Bird Gets the Worm?
Here's...
Surna Cultivation Technologies Signs $2.1 Million Contract
This is the 4th Multi-Million Contract Awarded in the Last Couple Years, With Three in 2022 Alone!
LIVE CHART
An Additional Multi-Million Dollar Contract Signed for HVACD Systems
Louisville, Colorado, March...
Glutathione: The “Mother” of all Antioxidants…
Glutathione, also known as GSH, is a molecule found naturally in your body. It is produced by the liver and nerve cells in the...
Revive Therapeutics (RVVTF) Regulatory Update Archive.
April 12th, 2022 update. Discusses potentially halting the Study early due to positive efficacy based on other clinical outcomes evaluated such as the rate...
Revive Therapeutics (RVVTF, RVV): Updates and News Archive.
Recent Headlines
(See FDA Filing Submission at Bottom)
LIVE QUOTE
NEWS ARCHIVE INTRO
“These medicines have a sweet spot. If the day you get diagnosed with COVID you...
Amazing Sales of Paxlovid (CBS News).
"These medicines have a sweet spot. If the day you get diagnosed COVID you say 'forget it, I'll be fine,' and then several days...
Our Best Risk to Reward Idea Ever?
Adding Revive Therapeutics (RVVTF, RVV.CN) to the "2022, Biotech 12 Pack, 12 Biotech Stocks We Expect to Double" Watch List*.
If not our best ever,...
ImmixBio (IMMX) Announces Positive Clinical Trial Safety Data.
Demonstrates 100% Completion of Planned Treatment Cycles.
Immix Biopharma, Inc. Wed, January 19, 2022.
ImmixBio Announces Positive IMX-110 Phase 1b/2a Interim Clinical Trial Safety Data Demonstrating...
Latest article
United States Antimony (UAMY) on Fox News.
DALLAS, TX / ACCESS Newswire / June 4, 2025 / United States Antimony Corporation ("USAC," "US Antimony," the "Company"), (NYSE American: UAMY), announced today that its Chairman...
Institutional Analyst: Latest Newsletter.
Biotechnology, Beverages, Precious Metals, Psychedelics, and Technology.
Perpetua Resources (PPTA) Joins the Billion Dollar Club Launching Institutional Gold Analyst and Gold Investor Conference1. Adding Perpetua Resources...
Blue Ocean Equities Report on Antimony.
Antimony Macro Note: Don’t expect Sb prices to pull back anytime soon!
ANTIMONY MACRO NOTE
On Gold Investment Conference
A simply fantastic report (best in world) though...
